SK283626B6
(sk)
*
|
1994-07-08 |
2003-10-07 |
Astrazeneca Ab |
Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
HU227566B1
(en)
*
|
1995-09-21 |
2011-08-29 |
Pharma Pass Llc |
Acid-labile pharmaceutical composition containing omeprazole and process for its preparation
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600072D0
(sv)
*
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients II
|
SE9600070D0
(sv)
*
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE512835C2
(sv)
*
|
1996-01-08 |
2000-05-22 |
Astrazeneca Ab |
Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
|
SE9600071D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients I
|
SE9602442D0
(sv)
*
|
1996-06-20 |
1996-06-20 |
Astra Ab |
Administration of pharmaceuticals
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
PL337888A1
(en)
*
|
1997-07-03 |
2000-09-11 |
Du Pont Pharm Co |
Imidazoprimidines and imidazopyridines for use in treating neurological disorders
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US20050244497A1
(en)
*
|
1997-11-05 |
2005-11-03 |
Wockhardt Limited |
Delayed delivery system for acid-sensitive drugs
|
US6174548B1
(en)
*
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6602522B1
(en)
*
|
1997-11-14 |
2003-08-05 |
Andrx Pharmaceuticals L.L.C. |
Pharmaceutical formulation for acid-labile compounds
|
AU751066B2
(en)
*
|
1997-12-08 |
2002-08-08 |
Nycomed Gmbh |
Novel administration form comprising an acid-labile active compound
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
FR2774288B1
(fr)
*
|
1998-01-30 |
2001-09-07 |
Ethypharm Sa |
Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
|
KR100554924B1
(ko)
*
|
1998-05-18 |
2006-03-03 |
다케다 야쿠힌 고교 가부시키가이샤 |
구강내 붕괴 정제
|
US6365589B1
(en)
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
DE69924381T2
(de)
|
1998-07-28 |
2006-04-20 |
Takeda Pharmaceutical Co. Ltd. |
Leicht zerfallende feste zubereitung
|
PT1105105E
(pt)
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
WO2000026185A2
(en)
*
|
1998-10-30 |
2000-05-11 |
The Curators Of The University Of Missouri |
Omeprazole solution and method of using same
|
DE69918854T2
(de)
|
1998-11-18 |
2005-07-21 |
Astrazeneca Ab |
Verbesserter chemischer prozess und eine pharmazeutische zubereitung
|
US6174902B1
(en)
|
1999-04-28 |
2001-01-16 |
Sepracor Inc. |
R-rabeprazole compositions and methods
|
FR2793688B1
(fr)
*
|
1999-05-21 |
2003-06-13 |
Ethypharm Lab Prod Ethiques |
Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
|
IL146504A0
(en)
|
1999-06-07 |
2002-07-25 |
Byk Gulden Lomberg Chem Fab |
Pharmaceutical compositions containing an acid-labile active compound and processes for the preparation thereof
|
IL130602A0
(en)
*
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
ES2168043B1
(es)
*
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
WO2002004411A1
(en)
|
2000-07-07 |
2002-01-17 |
The Administrators Of The Tulane Educational Fund |
Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
EP1341528B1
(en)
|
2000-12-07 |
2012-01-18 |
Nycomed GmbH |
Rapidly disintegrating tablet comprising an acid-labile active ingredient
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
US8765176B2
(en)
|
2001-06-20 |
2014-07-01 |
Takeda Pharmaceutical Campany Limited |
Method of manufacturing tablet
|
JP5138856B2
(ja)
*
|
2001-06-20 |
2013-02-06 |
武田薬品工業株式会社 |
錠剤の製造方法
|
DE60237294D1
(de)
*
|
2001-09-28 |
2010-09-23 |
Mcneil Ppc Inc |
Pharmazeutische zusammensetzung auf fondantbasis
|
JP4331930B2
(ja)
*
|
2001-10-17 |
2009-09-16 |
武田薬品工業株式会社 |
酸に不安定な薬物の高含量顆粒
|
DK1459737T3
(da)
|
2001-10-17 |
2013-01-02 |
Takeda Pharmaceutical |
Granulat indeholdende syreustabilt kemisk middel i stor mængde
|
JP2006282677A
(ja)
*
|
2001-10-17 |
2006-10-19 |
Takeda Chem Ind Ltd |
酸に不安定な薬物の高含量顆粒
|
ES2198195B1
(es)
*
|
2001-12-18 |
2004-10-01 |
Laboratorios Del Dr. Esteve, S.A. |
Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
|
CA2472103A1
(en)
*
|
2002-01-25 |
2003-08-07 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
US7125563B2
(en)
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
US6902746B2
(en)
*
|
2002-07-03 |
2005-06-07 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
FR2845289B1
(fr)
*
|
2002-10-04 |
2004-12-03 |
Ethypharm Sa |
Spheroides, procede de preparation et compositions pharmaceutiques.
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
FR2845917B1
(fr)
*
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
|
US9107804B2
(en)
*
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
WO2004066982A1
(en)
*
|
2003-01-31 |
2004-08-12 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and processes for their preparation
|
CA2517005A1
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
WO2004074285A1
(en)
*
|
2003-02-24 |
2004-09-02 |
Mitsubishi Pharma Corporation |
The enantiomer of tenatoprazole and the use thereof in therapy
|
US20040213847A1
(en)
*
|
2003-04-23 |
2004-10-28 |
Matharu Amol Singh |
Delayed release pharmaceutical compositions containing proton pump inhibitors
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
WO2005004921A1
(en)
*
|
2003-07-11 |
2005-01-20 |
Astrazeneca Ab |
Solid composition comprising a proton pump inhibitor
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2531566C
(en)
*
|
2003-07-18 |
2013-05-07 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
JP2006528181A
(ja)
*
|
2003-07-18 |
2006-12-14 |
サンタラス インコーポレイティッド |
酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
|
AR045068A1
(es)
*
|
2003-07-23 |
2005-10-12 |
Univ Missouri |
Formulacion de liberacion inmediata de composiciones farmaceuticas
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
JP2005306778A
(ja)
*
|
2004-04-21 |
2005-11-04 |
Basf Ag |
徐放性製剤及びその製造方法
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2569961A1
(en)
*
|
2004-06-10 |
2005-12-29 |
Glatt Air Techniques, Inc |
Controlled release pharmaceutical formulation
|
AU2005264864B2
(en)
|
2004-06-16 |
2011-08-11 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
FR2871800B1
(fr)
*
|
2004-06-17 |
2006-08-25 |
Sidem Pharma Sa Sa |
Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
|
US20050281876A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US20060134210A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Astrazeneca Ab |
Solid dosage form comprising proton pump inhibitor and suspension made thereof
|
US8673352B2
(en)
*
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
EP1813275A1
(en)
*
|
2005-12-20 |
2007-08-01 |
Teva Pharmaceutical Industries Ltd |
Lansoprazole orally disintegrating tablets
|
EP1962844A2
(en)
*
|
2005-12-20 |
2008-09-03 |
Teva Pharmaceutical Industries Ltd |
Lansoprazole orally disintegrating tablets
|
US20070141151A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Silver David I |
Lansoprazole orally disintegrating tablets
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
MY151468A
(en)
*
|
2005-12-28 |
2014-05-30 |
Takeda Pharmaceutical |
Controlled release solid preparation
|
US20070154542A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
CN101453993A
(zh)
*
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
US9532945B2
(en)
*
|
2006-04-04 |
2017-01-03 |
Kg Acquisition Llc |
Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
|
BRPI0709745A2
(pt)
*
|
2006-04-04 |
2011-07-26 |
Cogentus Pharmaceuticals Inc |
forma de dosagem oral, e, mÉtodo para prevenir ou reduzir a severidade, duraÇço, e/ou sintomas de um distérbio gastrintestinal
|
US20090068263A1
(en)
*
|
2006-04-20 |
2009-03-12 |
Themis Laboratories Private Limited |
Multiple unit compositions
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007138606A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
CN101500553B
(zh)
*
|
2006-07-25 |
2012-04-18 |
维克塔有限公司 |
联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法
|
AU2007276874B2
(en)
*
|
2006-07-28 |
2010-08-19 |
Dr. Reddy's Laboratories Ltd. |
Granular pharmaceutical compositions
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
TR200605624A2
(tr)
*
|
2006-10-10 |
2008-05-21 |
Nobel İlaç Sanayi̇ Ve Ti̇caret Aş. |
Farmasötik dozaj şekli
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
US8352042B2
(en)
*
|
2006-11-28 |
2013-01-08 |
The Alfred E. Mann Foundation For Scientific Research |
Remote controls and ambulatory medical systems including the same
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
DE102007009242A1
(de)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets mit magensaftresistenter Wirkstoff-Matix
|
EP2044932A1
(en)
*
|
2007-10-04 |
2009-04-08 |
Laboratorios del Dr. Esteve S.A. |
Mechanical protective layer for solid dosage forms
|
CN102014638A
(zh)
|
2007-10-12 |
2011-04-13 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
CA2716367C
(en)
|
2008-02-20 |
2015-05-26 |
The Curators Of The University Of Missouri |
Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
|
KR20100129761A
(ko)
|
2008-03-11 |
2010-12-09 |
다케다 야쿠힌 고교 가부시키가이샤 |
경구 붕해 고형 제제
|
TWI519322B
(zh)
*
|
2008-04-15 |
2016-02-01 |
愛戴爾製藥股份有限公司 |
包含弱鹼性藥物及控制釋放劑型之組合物
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
WO2009137648A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Aptapharma, Inc. |
Multilayer proton pump inhibitor tablets
|
EP2345408A3
(en)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Acid labile drug formulations
|
PL2538955T3
(pl)
|
2010-02-25 |
2016-04-29 |
Evonik Roehm Gmbh |
Formulacja farmaceutyczna lub nutraceutyczna
|
WO2011138797A2
(en)
|
2010-05-04 |
2011-11-10 |
Cadila Healthcare Limited |
Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
|
MX2013000827A
(es)
|
2010-07-22 |
2013-06-28 |
Lupin Ltd |
Composicion de tableta de unidad multiple.
|
IT1401284B1
(it)
*
|
2010-08-06 |
2013-07-18 |
Valpharma S P A |
Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system).
|
EP2468263A1
(en)
*
|
2010-12-23 |
2012-06-27 |
Laboratorios Del. Dr. Esteve, S.A. |
Compressed solid dosage forms
|
CN102805735A
(zh)
*
|
2011-06-21 |
2012-12-05 |
寿光富康制药有限公司 |
一种埃索美拉唑肠溶微丸片及其制备方法
|
RU2647472C2
(ru)
*
|
2011-11-02 |
2018-03-15 |
Лабораторьос Дель Др. Эстеве, С.А. |
Фармацевтическая композиция омепразола
|
GB201417828D0
(en)
|
2014-10-08 |
2014-11-19 |
Cereno Scient Ab |
New methods and compositions
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CZ2017315A3
(cs)
|
2017-06-02 |
2018-12-12 |
Zentiva, K.S. |
Dávkovací jednotka s PPI (inhibitory protonové pumpy)
|